resiquimod has been researched along with Leishmaniasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Coimbra, ES; da Silva, AD; Dib, PRB; Fung, J; Granato, JT; Kaushik, D; Macedo, GC; Petrovsky, N; Piplani, S; Salunke, DB | 1 |
| Bahrami, F; Niknam, HM; Rostamian, M | 1 |
| Buates, S; Matlashewski, G | 1 |
3 other study(ies) available for resiquimod and Leishmaniasis
| Article | Year |
|---|---|
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent.
Topics: Animals; Antiprotozoal Agents; Cytokines; Female; Humans; Imidazoles; Imiquimod; Inflammation; Leishmania; Leishmaniasis; Macrophages, Peritoneal; Mice, Inbred BALB C; Nitric Oxide; Reactive Oxygen Species; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2021 |
Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Cytokines; Disease Models, Animal; Female; Imidazoles; Leishmania tropica; Leishmaniasis; Leishmaniasis Vaccines; Lipid A; Mice, Inbred BALB C; Parasite Load; Protozoan Proteins; Random Allocation; Recombinant Proteins; Toll-Like Receptors; Vaccination; Vaccines, Inactivated | 2018 |
Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Bone Marrow Cells; Female; Imiquimod; Leishmania donovani; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-fos; Signal Transduction; Trypanocidal Agents | 1999 |